ID ASB1_HUMAN Reviewed; 335 AA.
AC Q9Y576; A6NL50; Q4ZG29; Q9ULS4;
DT 10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1999, sequence version 1.
DT 04-NOV-2026, entry version 194.
DE RecName: Full=Ankyrin repeat and SOCS box protein 1;
DE Short=ASB-1;
GN Name=ASB1; Synonyms=KIAA1146;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=11111040; DOI=10.1016/s0378-1119(00)00402-9;
RA Kile B.T., Viney E.M., Willson T.A., Brodnicki T.C., Cancilla M.R.,
RA Herlihy A.S., Croker B.A., Baca M., Nicola N.A., Hilton D.J.,
RA Alexander W.S.;
RT "Cloning and characterization of the genes encoding the ankyrin repeat and
RT SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4.";
RL Gene 258:31-41(2000).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=15815621; DOI=10.1038/nature03466;
RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA Wilson R.K.;
RT "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT 4.";
RL Nature 434:724-731(2005).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Placenta;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 65-335.
RC TISSUE=Brain;
RX PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT "Characterization of cDNA clones selected by the GeneMark analysis from
RT size-fractionated cDNA libraries from human brain.";
RL DNA Res. 6:329-336(1999).
RN [5]
RP FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, AND INTERACTION WITH CUL5 AND
RP RNF7.
RX PubMed=16325183; DOI=10.1016/j.febslet.2005.11.016;
RA Kohroki J., Nishiyama T., Nakamura T., Masuho Y.;
RT "ASB proteins interact with cullin5 and Rbx2 to form E3 ubiquitin ligase
RT complexes.";
RL FEBS Lett. 579:6796-6802(2005).
RN [6]
RP FUNCTION.
RX PubMed=21119685; DOI=10.1038/cr.2010.165;
RA Nie L., Zhao Y., Wu W., Yang Y.Z., Wang H.C., Sun X.H.;
RT "Notch-induced Asb2 expression promotes protein ubiquitination by forming
RT non-canonical E3 ligase complexes.";
RL Cell Res. 21:754-769(2011).
RN [7]
RP FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TAB2 AND TAB3.
RX PubMed=33431678; DOI=10.1073/pnas.2015416118;
RA Hou P., Jia P., Yang K., Li Z., Tian T., Lin Y., Zeng W., Xing F., Chen Y.,
RA Li C., Liu Y., Guo D.;
RT "An unconventional role of an ASB family protein in NF-kappaB activation
RT and inflammatory response during microbial infection and colitis.";
RL Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN [8]
RP FUNCTION.
RX PubMed=39113857; DOI=10.62347/feiz7492;
RA Zhao C., Xu Z., Que H., Zhang K., Wang F., Tan R., Fan C.;
RT "ASB1 inhibits prostate cancer progression by destabilizing CHCHD3 via K48-
RT linked ubiquitination.";
RL Am. J. Cancer Res. 14:3404-3418(2024).
RN [9]
RP VARIANT GLY-23.
RX PubMed=35246562; DOI=10.1038/s41525-022-00286-0;
RA Gonzalez-Del Pozo M., Fernandez-Suarez E., Bravo-Gil N., Mendez-Vidal C.,
RA Martin-Sanchez M., Rodriguez-de la Rua E., Ramos-Jimenez M.,
RA Morillo-Sanchez M.J., Borrego S., Antinolo G.;
RT "A comprehensive WGS-based pipeline for the identification of new candidate
RT genes in inherited retinal dystrophies.";
RL NPJ Genom. Med. 7:17-17(2022).
CC -!- FUNCTION: Probable substrate-recognition component of a SCF-like ECS
CC (Elongin-Cullin-SOCS-box protein) E3 ligase complex which mediates the
CC ubiquitination and subsequent proteasomal degradation of target
CC proteins (PubMed:16325183). Mediates Notch-induced ubiquitination and
CC degradation of TCF3/E2A and JAK2 (PubMed:21119685). Functions as a
CC tumor suppressor by enhancing CHCHD3 'Lys-48'-linked ubiquitination,
CC leading to inhibition of the CHCHD3/ROS signaling pathway
CC (PubMed:39113857). Suppresses TAB2-linked 'Lys-48' polyubiquitination
CC and consequently facilitates the initiation of NF-kappa-B and MAPK
CC signaling cascades (PubMed:33431678). May play a role in testis
CC development (By similarity). {ECO:0000250|UniProtKB:Q9WV74,
CC ECO:0000269|PubMed:16325183, ECO:0000269|PubMed:21119685,
CC ECO:0000269|PubMed:33431678, ECO:0000269|PubMed:39113857}.
CC -!- PATHWAY: Protein modification; protein ubiquitination.
CC -!- SUBUNIT: Interacts with CUL5 and RNF7 (PubMed:16325183). Interacts with
CC TAB2 and TAB3 (PubMed:33431678). {ECO:0000269|PubMed:16325183,
CC ECO:0000269|PubMed:33431678}.
CC -!- INTERACTION:
CC Q9Y576; Q93034: CUL5; NbExp=8; IntAct=EBI-2323092, EBI-1057139;
CC Q9Y576; Q92993: KAT5; NbExp=3; IntAct=EBI-2323092, EBI-399080;
CC Q9Y576; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-2323092, EBI-11742507;
CC Q9Y576; Q9UBF6: RNF7; NbExp=5; IntAct=EBI-2323092, EBI-398632;
CC Q9Y576; Q15047-2: SETDB1; NbExp=3; IntAct=EBI-2323092, EBI-9090795;
CC Q9Y576; P61981: YWHAG; NbExp=3; IntAct=EBI-2323092, EBI-359832;
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:33431678}.
CC -!- DOMAIN: The SOCS box domain mediates the interaction with the Elongin
CC BC complex, an adapter module in different E3 ubiquitin-protein ligase
CC complexes. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the ankyrin SOCS box (ASB) family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF156777; AAD41894.1; -; mRNA.
DR EMBL; AC016999; AAX88934.1; -; Genomic_DNA.
DR EMBL; BC014528; AAH14528.1; -; mRNA.
DR EMBL; AB032972; BAA86460.1; -; mRNA.
DR CCDS; CCDS33416.1; -.
DR RefSeq; NP_001035535.1; NM_001040445.3.
DR AlphaFoldDB; Q9Y576; -.
DR SMR; Q9Y576; -.
DR BioGRID; 119668; 38.
DR CORUM; Q9Y576; -.
DR FunCoup; Q9Y576; 251.
DR IntAct; Q9Y576; 16.
DR NDEx; IQUERY-CP-ASB1; 1 NDEx IQuery Curated Pathway.
DR STRING; 9606.ENSP00000264607; -.
DR iPTMnet; Q9Y576; -.
DR PhosphoSitePlus; Q9Y576; -.
DR BioMuta; ASB1; -.
DR DMDM; 20532005; -.
DR jPOST; Q9Y576; -.
DR MassIVE; Q9Y576; -.
DR PaxDb; 9606-ENSP00000264607; -.
DR PeptideAtlas; Q9Y576; -.
DR ProteomicsDB; 86308; -.
DR Pumba; Q9Y576; -.
DR Antibodypedia; 1137; 37 antibodies from 14 providers.
DR DNASU; 51665; -.
DR Ensembl; ENST00000264607.9; ENSP00000264607.4; ENSG00000065802.13.
DR GeneID; 51665; -.
DR KEGG; hsa:51665; -.
DR MANE-Select; ENST00000264607.9; ENSP00000264607.4; NM_001040445.3; NP_001035535.1.
DR UCSC; uc002vyg.4; human.
DR AGR; HGNC:16011; -.
DR ClinPGx; PA25027; -.
DR CTD; 51665; -.
DR DisGeNET; 51665; -.
DR GeneCards; ASB1; -.
DR HGNC; HGNC:16011; ASB1.
DR HPA; ENSG00000065802; Low tissue specificity.
DR MalaCards; ASB1; -.
DR MIM; 605758; gene.
DR OpenTargets; ENSG00000065802; -.
DR VEuPathDB; HostDB:ENSG00000065802; -.
DR eggNOG; KOG0504; Eukaryota.
DR GeneTree; ENSGT00940000153969; -.
DR HOGENOM; CLU_053981_0_0_1; -.
DR InParanoid; Q9Y576; -.
DR OMA; AATKFNH; -.
DR OrthoDB; 4735278at2759; -.
DR PAN-GO; Q9Y576; 3 GO annotations based on evolutionary models.
DR PhylomeDB; Q9Y576; -.
DR PathwayCommons; Q9Y576; -.
DR Reactome; R-HSA-8951664; Neddylation.
DR Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR SignaLink; Q9Y576; -.
DR UniPathway; UPA00143; -.
DR Agora; ENSG00000065802; -.
DR BioGRID-ORCS; 51665; 14 hits in 1194 CRISPR screens.
DR ChiTaRS; ASB1; human.
DR GeneWiki; ASB1; -.
DR GenomeRNAi; 51665; -.
DR Pharos; Q9Y576; Tdark.
DR PRO; PR:Q9Y576; -.
DR Proteomes; UP000005640; Chromosome 2.
DR RNAct; Q9Y576; protein.
DR Bgee; ENSG00000065802; Expressed in apex of heart and 186 other cell types or tissues.
DR ExpressionAtlas; Q9Y576; baseline and differential.
DR GO; GO:0005737; C:cytoplasm; EXP:UniProtKB.
DR GO; GO:0005829; C:cytosol; TAS:Reactome.
DR GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR GO; GO:1990756; F:ubiquitin-like ligase-substrate adaptor activity; IBA:GO_Central.
DR GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR GO; GO:0001818; P:negative regulation of cytokine production; NAS:UniProtKB.
DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR CDD; cd03720; SOCS_ASB1; 1.
DR FunFam; 1.10.750.20:FF:000001; Ankyrin repeat and SOCS box containing 1; 1.
DR FunFam; 1.25.40.20:FF:000119; Ankyrin repeat and SOCS box containing 1; 1.
DR Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR Gene3D; 1.10.750.20; SOCS box; 1.
DR InterPro; IPR002110; Ankyrin_rpt.
DR InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR InterPro; IPR037331; ASB1_SOCS.
DR InterPro; IPR001496; SOCS_box.
DR InterPro; IPR036036; SOCS_box-like_dom_sf.
DR PANTHER; PTHR24173:SF27; ANKYRIN REPEAT AND SOCS BOX PROTEIN 1; 1.
DR PANTHER; PTHR24173; ANKYRIN REPEAT CONTAINING; 1.
DR Pfam; PF12796; Ank_2; 1.
DR Pfam; PF13606; Ank_3; 1.
DR Pfam; PF07525; SOCS_box; 1.
DR PRINTS; PR01415; ANKYRIN.
DR SMART; SM00248; ANK; 5.
DR SMART; SM00969; SOCS_box; 1.
DR SUPFAM; SSF48403; Ankyrin repeat; 1.
DR SUPFAM; SSF158235; SOCS box-like; 1.
DR PROSITE; PS50297; ANK_REP_REGION; 1.
DR PROSITE; PS50088; ANK_REPEAT; 3.
DR PROSITE; PS50225; SOCS; 1.
PE 1: Evidence at protein level;
KW ANK repeat; Cytoplasm; Developmental protein; Proteomics identification;
KW Reference proteome; Repeat; Ubl conjugation pathway.
FT CHAIN 1..335
FT /note="Ankyrin repeat and SOCS box protein 1"
FT /id="PRO_0000066923"
FT REPEAT 36..68
FT /note="ANK 1"
FT REPEAT 77..106
FT /note="ANK 2"
FT REPEAT 110..139
FT /note="ANK 3"
FT REPEAT 143..172
FT /note="ANK 4"
FT REPEAT 191..220
FT /note="ANK 5"
FT REPEAT 235..265
FT /note="ANK 6"
FT DOMAIN 286..335
FT /note="SOCS box"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00194"
FT VARIANT 23
FT /note="W -> G (found in a patient with a form of retinitis
FT pigmentosa; uncertain significance)"
FT /evidence="ECO:0000269|PubMed:35246562"
FT /id="VAR_091941"
SQ SEQUENCE 335 AA; 37014 MW; 0843C96AD1AF60D9 CRC64;
MAEGGSPDGR AGPGSAGRNL KEWLREQFCD HPLEHCEDTR LHDAAYVGDL QTLRSLLQEE
SYRSRINEKS VWCCGWLPCT PLRIAATAGH GSCVDFLIRK GAEVDLVDVK GQTALYVAVV
NGHLESTQIL LEAGADPNGS RHHRSTPVYH ASRVGRADIL KALIRYGADV DVNHHLTPDV
QPRFSRRLTS LVVCPLYISA AYHNLQCFRL LLLAGANPDF NCNGPVNTQG FYRGSPGCVM
DAVLRHGCEA AFVSLLVEFG ANLNLVKWES LGPESRGRRK VDPEALQVFK EARSVPRTLL
CLCRVAVRRA LGKHRLHLIP SLPLPDPIKK FLLHE
//